Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | TSHR | P16473 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | BLM | P54132 | 3/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.66 |
| ▸ | MPO | P05164 | 2/20 | 0.66 |
| ▸ | PTPRA | P18433 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 4/20 | 0.61 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248870 | 1.00 | KMT2A (0.66) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL18029199 | 1.00 | KMT2A (0.66) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL7096864 | 1.00 | KMT2A (0.66) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL2330930 | 1.00 | KMT2A (0.66) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL30381733 | 1.00 | KMT2A (0.66) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL4262937 | 0.89 | HTR2A (0.60) | KMT2ATSHRKDM4ELMNAMAPT | |
| SCHEMBL4262934 | 0.89 | HTR2A (0.60) | KMT2ATSHRKDM4ELMNAMAPT | |
| Fluorotryptophane SCHEMBL125000 | 0.89 | HTR2A (0.73) | KMT2ATSHRKDM4ELMNAMAPT | |
| Fluorotryptophane SCHEMBL29623154 | 0.89 | HTR2A (0.73) | KMT2ATSHRKDM4ELMNAMAPT | |
| Fluorotryptophane SCHEMBL29358068 | 0.89 | HTR2A (0.73) | KMT2ATSHRKDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| EP-4659023-A1 | METHOD OF PREDICTING SUCCESS OF A CANCER THERAPY | Immusmol SAS (FR) | 2025-12-10 | — | — | EP | claimed |
| US-20250361273-A1 | METHODS AND COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC | 2025-11-27 | — | — | US | claimed |
| WO-2025245483-A1 | METHODS AND COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-11-27 | — | — | WO | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025128626-A1 | HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| WO-2025128624-A2 | HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| CN-120082575-A | Tryptophan synthase trpB modified gene and preparation method of 6-fluoro-L-tryptophan | 宿州学院 | 2025-06-03 | — | — | CN | claimed |
| CN-119613495-A | C3 complement inhibition polypeptide, preparation method and medical application thereof | 远森制药（杭州）有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-112218875-B | Method for synthesizing arginine-containing peptides | 帝斯曼知识产权资产管理有限公司 | 2024-10-11 | — | — | CN | claimed |
| EP-0450327-B1 | Biosynthesis of rebeccamycin analogs by tryptophan analogs feeding | BRISTOL MYERS SQUIBB CO (US) | 1996-06-05 | — | — | EP | claimed |
| US-5468849-A | Rebeccamycin analogs by tryptophan analogs feeding | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-21 | — | — | US | claimed |
| EP-0183006-B1 | A RECOMBINANT DNA-MOLECULE, CORYNEFORM BACTERIA CARRYING RECOMBINANT DNA AND PROCESS FOR PRODUCING AN AROMATIC AMINO ACID BY USING THE SAME | AJINOMOTO CO., INC. (JP) | 1992-02-26 | — | — | EP | claimed |
| EP-0450327-A1 | Biosynthesis of rebeccamycin analogs by tryptophan analogs feeding | Bristol-Myers Squibb Company (US) | 1991-10-09 | — | — | EP | claimed |
| US-5034318-A | Culturing Coryneform glutamic acid producing bacteria with plasmids | AJINOMOTO CO., INC. (JP) | 1991-07-23 | — | — | US | claimed |
| US-5017481-A | Biosynthesis | AJINOMOTO CO., INC. (JP) | 1991-05-21 | — | — | US | claimed |
| US-4704394-A | SEROTONIN ANTAGONISTS | TECHNOLOGY UNLIMITED, INC. (US) | 1987-11-03 | — | — | US | claimed |
| EP-0183006-A2 | A recombinant DNA-molecule, coryneform bacteria carrying recombinant DNA and process for producing an aromatic amino acid by using the same | AJINOMOTO CO., INC. (JP) | 1986-06-04 | — | — | EP | claimed |
| US-4371614-A | E.Coli bacteria carrying recombinant plasmids and their use in the fermentative production of L-tryptophan | AJINOMOTO CO., INC. (JP) | 1983-02-01 | — | — | US | claimed |
| US-3930948-A | ENZYMATIC METHOD FOR PRODUCING AROMATIC ETHYLAMINES | AJINOMOTO CO., INC. (JA) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | KMT2A 1848/4885TSHR 1283/4885KDM4E 3819/4885 |
| US-20250361273-A1 | METHODS AND COMPOSITIONS | MC4R, GPR119, MC2R | KMT2A 3419/4885TSHR 120/4885KDM4E 2986/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | KMT2A 2188/4885TSHR 17/4885KDM4E 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.